Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
GnRH Antagonist Engineering: 3-(2-Methoxy-5-pyridyl)-alanine
2026-07-15
This study systematically explores the structural and functional consequences of incorporating 3-(2-methoxy-5-pyridyl)-alanine at position 3 in degarelix-based GnRH antagonists. By resolving the impact of stereochemistry on receptor antagonism and in vivo duration, the research refines understanding of peptide design strategies for endocrine modulation.
-
Lithium-Driven Exosomal Wnt10a Secretion Enhances Osteogenes
2026-07-15
This study uncovers how lithium promotes bone mesenchymal stem cell-mediated osteogenesis by facilitating Rab11a-dependent exosomal Wnt10a secretion and activating β-catenin signaling. The mechanistic insight supports new strategies for bone regeneration and highlights the relevance of Wnt pathway modulation in stem cell-based therapies.
-
IWP-2: Unlocking Wnt Pathway Inhibition for Translational Re
2026-07-14
This article explores the mechanistic rationale, experimental validation, and strategic utility of IWP-2—a potent Porcupine (PORCN) inhibitor—for advancing translational research in oncology, neurodevelopment, and immunology. By integrating recent findings on Wnt/β-catenin signaling, apoptosis, and epigenetic biomarkers, we offer actionable guidance for leveraging IWP-2 in experimental design and protocol optimization, positioning APExBIO’s IWP-2 as a keystone reagent for next-generation pathway-targeted research.
-
Eltanexor Modulates Wnt/β-catenin to Suppress Colorectal Tum
2026-07-14
The referenced study demonstrates that Eltanexor (KPT-8602), a second-generation XPO1 inhibitor, significantly reduces colorectal cancer (CRC) tumor burden by modulating the Wnt/β-catenin pathway and downregulating COX-2 expression. These findings highlight Eltanexor's potential as a chemopreventive agent in genetically high-risk CRC models and provide mechanistic insight into nuclear export inhibition in solid tumor research.
-
4-Ethylphenyl Sulfate: Applied Workflows for Gut-Brain and R
2026-07-13
4-Ethylphenyl sulfate serves as a dual-purpose biomarker and experimental tool, uniquely positioned for gut microbiota-brain interaction and renal dysfunction studies. APExBIO’s high-purity standard enables reproducible, translational workflows from mechanistic benchwork to biomaterial interface design.
-
CHIR-99021 (CT99021): Precision Tool for Vascular and Stem C
2026-07-13
Explore how CHIR-99021 (CT99021) uniquely advances both embryonic stem cell pluripotency and vascular modeling by integrating GSK-3 inhibition with emerging insights into vasculogenesis and MAPK pathway regulation. Discover protocol guidance and nuanced applications for front-line stem cell and vascular research.
-
ABT-199 (Venetoclax): Potent Bcl-2 Inhibitor for Apoptosis R
2026-07-12
ABT-199 (Venetoclax) is a highly selective Bcl-2 inhibitor that induces apoptosis in hematologic malignancy models. Its sub-nanomolar affinity and selectivity profile make it a benchmark tool for dissecting the mitochondrial apoptotic pathway. APExBIO provides research-grade ABT-199 under SKU A8194 for laboratory use.
-
Efficient Synthesis of Deuterium-Labeled Degarelix Acetate
2026-07-10
This study introduces a robust and scalable method for synthesizing deuterium-labeled degarelix acetate, a third-generation GnRH antagonist with clinical relevance in androgen-related diseases. The work streamlines access to stable isotope-labeled standards for pharmacokinetic and metabolic research, enhancing the rigor of clinical and translational workflows.
-
IWR-1-endo: Deep Mechanistic Insights for Wnt Pathway Modula
2026-07-09
Explore the unique mechanism and advanced research applications of IWR-1-endo, a potent Wnt signaling inhibitor. This article delivers in-depth analysis, practical protocol guidance, and integrates new molecular insights from large-scale single-nucleus sequencing.
-
HLY78: Wnt/β-Catenin Pathway Modulator for Precision Researc
2026-07-09
HLY78 enables robust, ligand-dependent activation of the Wnt/β-catenin pathway, offering researchers precise control in developmental and fibrosis models. Its Axin-targeted mechanism facilitates reproducible induction of stem cell markers, with proven utility in both zebrafish and mammalian workflows.
-
Artesunate: Applied Workflows for Advanced Cancer Research
2026-07-08
Artesunate, a potent artemisinin derivative from APExBIO, empowers researchers to dissect complex cell death pathways in small cell lung and esophageal squamous cell carcinoma models. This guide details optimized protocols, advanced troubleshooting strategies, and actionable insights inspired by cutting-edge in vitro evaluation methodology.
-
IWP-2: Wnt Production Inhibitor for Advanced Cancer Research
2026-07-08
IWP-2, a selective Wnt production inhibitor from APExBIO, empowers researchers to dissect Wnt/β-catenin signaling with precision in cancer and neurodevelopmental assays. Discover how its robust potency and workflow versatility enable reproducible apoptosis assays, migration studies, and translational investigations.
-
Indometacin Sodium Promotes Remyelination via β-Catenin Regu
2026-07-07
Preisner et al. (2015) reveal that indometacin, a non-steroidal anti-inflammatory drug, enhances endogenous remyelination by modulating the Wnt/β-catenin pathway and promoting oligodendrocyte differentiation. These findings suggest a potential adjunctive strategy for multiple sclerosis therapies targeting remyelination.
-
Morphological Profiling Reveals HSPB7 Rescue in Titin Cardio
2026-07-07
This study introduces CARDIO, a high-content imaging platform for profiling morphological and functional changes in human stem cell-derived cardiomyocytes. By applying this approach to titin-deficient models of dilated cardiomyopathy, the authors identified HSPB7 loss as a genetic perturbation that unexpectedly restores contractile function, offering new insight into heart failure mechanisms.
-
MnTBAP Chloride: Advancing Mitochondrial Redox Stress Models
2026-07-06
MnTBAP Chloride empowers oxidative stress and neuroinflammation research with robust, cell-permeable SOD mimetic activity, enabling reproducible protection in both cell culture and animal models. Its validated role in modulating mitochondrial dysfunction and inflammation underpins its value for dissecting complex stress-linked pathologies. Researchers benefit from standardized workflows, practical troubleshooting, and data-backed comparative advantages that set MnTBAP Chloride apart.